Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 4
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
- View all (634)
- Volume 17, 2024 (13)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Archive: Volume 4, 2011
Sulfation of fulvestrant by human liver cytosols and recombinant SULT1A1 and SULT1E1
Edavana VK, Yu X, Dhakal IB, Williams S, Ning B, Cook IT, Caldwell D, Falany CN, Kadlubar S
Pharmacogenomics and Personalized Medicine 2011, 4:137-145
Published Date: 17 November 2011
Role of cytochrome P450 genotype in the steps toward personalized drug therapy
Cavallari LH, Jeong H, Bress A
Pharmacogenomics and Personalized Medicine 2011, 4:123-136
Published Date: 7 November 2011
Clinical application of high throughput molecular screening techniques for pharmacogenomics
Wiita AP, Schrijver I
Pharmacogenomics and Personalized Medicine 2011, 4:109-121
Published Date: 8 September 2011
Clinical implementation of RNA signatures for pharmacogenomic decision-making
Tang W, Hu Z, Muallem H, Gulley ML
Pharmacogenomics and Personalized Medicine 2011, 4:95-107
Published Date: 8 September 2011
Role of 5-HT2C receptor gene variants in antipsychotic-induced weight gain
Wallace TJM, Zai CC, Brandl EJ, Müller DJ
Pharmacogenomics and Personalized Medicine 2011, 4:83-93
Published Date: 18 August 2011
Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family
Lucire Y, Crotty C
Pharmacogenomics and Personalized Medicine 2011, 4:65-81
Published Date: 1 August 2011
ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer
Vaezi A, Feldman CH, Niedernhofer LJ
Pharmacogenomics and Personalized Medicine 2011, 4:47-63
Published Date: 20 July 2011
A genetic approach to the prediction of drug side effects: bleomycin induces concordant phenotypes in mice of the collaborative cross
Gelinas R, Chesler EJ, Vasconcelos D, Miller DR, Yuan Y, Wang K, Galas D
Pharmacogenomics and Personalized Medicine 2011, 4:35-45
Published Date: 4 July 2011
Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy
Bluth MH, Li J
Pharmacogenomics and Personalized Medicine 2011, 4:11-33
Published Date: 1 April 2011
Optimizing response to gefitinib in the treatment of non-small-cell lung cancer
Pietro Carotenuto, Cristin Roma, Anna Maria Rachiglio, et al
Pharmacogenomics and Personalized Medicine 2011, 4:1-9
Published Date: 14 March 2011